Home/AmideBio/Derek Watson, MBA

DW

Derek Watson, MBA

Fractional CFO

Therapeutic Areas

Metabolic Disease

AmideBio Pipeline

Drug	Indication	Phase
Undisclosed Peptide Programs	Metabolic Disease	Preclinical

Leadership Team at AmideBio

Pawel Fludzinski, PhD

CEO, President and Board Member

Michael H. B. Stowell, PhD

CSO, Founder and Board Member

Stephen Eisenberg, PhD

Director, Molecular Biology

View full AmideBio profile